Generation Bio
GBIO
GBIO
83 hedge funds and large institutions have $247M invested in Generation Bio in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 29
13% less funds holding
Funds holding: 95 → 83 (-12)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
Holders
83
Holding in Top 10
1
Calls
$138K
Puts
$13K
Top Buyers
| 1 | +$8.41M | |
| 2 | +$1.79M | |
| 3 | +$1.65M | |
| 4 |
ACM
Atika Capital Management
New York
|
+$1.53M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$479K |
Top Sellers
| 1 | -$4.91M | |
| 2 | -$1.39M | |
| 3 | -$1.13M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.1M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$846K |